{"entity":{"type":"insider","cik":"0001518231","url":"/insider/0001518231","json_url":"/insider/0001518231.json","name":"China Renaissance Capital Investment II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":9,"first":"2011-11-18","last":"2012-02-17","span_basis":"filed_date"},"name_variants":[{"name":"China Renaissance Capital Investment II, L.P.","source":"filing","n_filings":9,"first_seen":"2011-11-18","last_seen":"2012-02-17"}],"transactions":[{"id":3380519,"accession":"0001209191-12-011254","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-011254","line_url":"/filing/0001209191-12-011254#line-3","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Key Gate Investments Ltd; China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; China Harvest Fund II, LP","owner_display_name":"Key Gate Investments Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76700.0,"shares_display":"76,700","price_per_share":22.07,"price_display":"22.07","price_state":"stated","total_value":1692769.0,"total_display":"1,692,769.00","total_whole":"1,692,769","shares_owned_after":2779003.0,"shares_owned_after_display":"2,779,003","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-17","filed_date":"2012-02-17","scope":"insider"},{"id":3380518,"accession":"0001209191-12-011254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-011254","line_url":"/filing/0001209191-12-011254#line-2","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Key Gate Investments Ltd; China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; China Harvest Fund II, LP","owner_display_name":"Key Gate Investments Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.93,"price_display":"21.93","price_state":"stated","total_value":219300.0,"total_display":"219,300.00","total_whole":"219,300","shares_owned_after":2855703.0,"shares_owned_after_display":"2,855,703","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-16","filed_date":"2012-02-17","scope":"insider"},{"id":3380517,"accession":"0001209191-12-011254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-011254","line_url":"/filing/0001209191-12-011254#line-1","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Key Gate Investments Ltd; China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; China Harvest Fund II, LP","owner_display_name":"Key Gate Investments Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":22.34,"price_display":"22.34","price_state":"stated","total_value":6702.0,"total_display":"6,702.00","total_whole":"6,702","shares_owned_after":2865703.0,"shares_owned_after_display":"2,865,703","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-15","filed_date":"2012-02-17","scope":"insider"},{"id":2978983,"accession":"0001209191-12-007875","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-007875","line_url":"/filing/0001209191-12-007875#line-3","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Key Gate Investments Ltd; China Renaissance Capital Investment II, L.P.; China Renaissance Capital Investment II GP; China Harvest Fund II, LP","owner_display_name":"Key Gate Investments Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.79,"price_display":"22.79","price_state":"stated","total_value":227900.0,"total_display":"227,900.00","total_whole":"227,900","shares_owned_after":2866003.0,"shares_owned_after_display":"2,866,003","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-06","filed_date":"2012-02-06","scope":"insider"},{"id":2978981,"accession":"0001209191-12-007875","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-007875","line_url":"/filing/0001209191-12-007875#line-2","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Key Gate Investments Ltd; China Renaissance Capital Investment II, L.P.; China Renaissance Capital Investment II GP; China Harvest Fund II, LP","owner_display_name":"Key Gate Investments Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13514.0,"shares_display":"13,514","price_per_share":22.31,"price_display":"22.31","price_state":"stated","total_value":301497.34,"total_display":"301,497.34","total_whole":"301,497","shares_owned_after":2876003.0,"shares_owned_after_display":"2,876,003","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-03","filed_date":"2012-02-06","scope":"insider"},{"id":2978974,"accession":"0001209191-12-007875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-007875","line_url":"/filing/0001209191-12-007875#line-1","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"Key Gate Investments Ltd; China Renaissance Capital Investment II, L.P.; China Renaissance Capital Investment II GP; China Harvest Fund II, LP","owner_display_name":"Key Gate Investments Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12837.0,"shares_display":"12,837","price_per_share":22.3,"price_display":"22.30","price_state":"stated","total_value":286265.1,"total_display":"286,265.10","total_whole":"286,265","shares_owned_after":2889517.0,"shares_owned_after_display":"2,889,517","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-02","filed_date":"2012-02-06","scope":"insider"},{"id":3350723,"accession":"0001209191-12-006708","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-006708","line_url":"/filing/0001209191-12-006708#line-3","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; Key Gate Investments Ltd; China Harvest Fund II, LP","owner_display_name":"China Renaissance Capital Investment II GP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":22.27,"price_display":"22.27","price_state":"stated","total_value":1002150.0,"total_display":"1,002,150.00","total_whole":"1,002,150","shares_owned_after":2902354.0,"shares_owned_after_display":"2,902,354","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-01","filed_date":"2012-02-01","scope":"insider"},{"id":3350717,"accession":"0001209191-12-006708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-006708","line_url":"/filing/0001209191-12-006708#line-2","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; Key Gate Investments Ltd; China Harvest Fund II, LP","owner_display_name":"China Renaissance Capital Investment II GP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3398.0,"shares_display":"3,398","price_per_share":22.19,"price_display":"22.19","price_state":"stated","total_value":75401.62,"total_display":"75,401.62","total_whole":"75,402","shares_owned_after":2947354.0,"shares_owned_after_display":"2,947,354","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-31","filed_date":"2012-02-01","scope":"insider"},{"id":3350710,"accession":"0001209191-12-006708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-006708","line_url":"/filing/0001209191-12-006708#line-1","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; Key Gate Investments Ltd; China Harvest Fund II, LP","owner_display_name":"China Renaissance Capital Investment II GP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1702.0,"shares_display":"1,702","price_per_share":22.13,"price_display":"22.13","price_state":"stated","total_value":37665.26,"total_display":"37,665.26","total_whole":"37,665","shares_owned_after":2950752.0,"shares_owned_after_display":"2,950,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-30","filed_date":"2012-02-01","scope":"insider"},{"id":3380117,"accession":"0001209191-12-005846","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-005846","line_url":"/filing/0001209191-12-005846#line-3","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II GP; Key Gate Investments Ltd; China Renaissance Capital Investment II, L.P.; China Harvest Fund II, LP","owner_display_name":"China Renaissance Capital Investment II GP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5538.0,"shares_display":"5,538","price_per_share":22.43,"price_display":"22.43","price_state":"stated","total_value":124217.34,"total_display":"124,217.34","total_whole":"124,217","shares_owned_after":2952454.0,"shares_owned_after_display":"2,952,454","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-27","filed_date":"2012-01-27","scope":"insider"},{"id":3380115,"accession":"0001209191-12-005846","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-005846","line_url":"/filing/0001209191-12-005846#line-2","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II GP; Key Gate Investments Ltd; China Renaissance Capital Investment II, L.P.; China Harvest Fund II, LP","owner_display_name":"China Renaissance Capital Investment II GP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4838.0,"shares_display":"4,838","price_per_share":22.46,"price_display":"22.46","price_state":"stated","total_value":108661.48,"total_display":"108,661.48","total_whole":"108,661","shares_owned_after":2957992.0,"shares_owned_after_display":"2,957,992","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-26","filed_date":"2012-01-27","scope":"insider"},{"id":3380113,"accession":"0001209191-12-005846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-005846","line_url":"/filing/0001209191-12-005846#line-1","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II GP; Key Gate Investments Ltd; China Renaissance Capital Investment II, L.P.; China Harvest Fund II, LP","owner_display_name":"China Renaissance Capital Investment II GP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":22.53,"price_display":"22.53","price_state":"stated","total_value":337950.0,"total_display":"337,950.00","total_whole":"337,950","shares_owned_after":2962830.0,"shares_owned_after_display":"2,962,830","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-25","filed_date":"2012-01-27","scope":"insider"},{"id":2817458,"accession":"0001209191-12-005158","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-005158","line_url":"/filing/0001209191-12-005158#line-1","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II, L.P.; China Renaissance Capital Investment II GP; China Harvest Fund II, LP; Key Gate Investments Ltd","owner_display_name":"China Renaissance Capital Investment II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19844.0,"shares_display":"19,844","price_per_share":22.16,"price_display":"22.16","price_state":"stated","total_value":439743.04,"total_display":"439,743.04","total_whole":"439,743","shares_owned_after":2977830.0,"shares_owned_after_display":"2,977,830","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-20","filed_date":"2012-01-24","scope":"insider"},{"id":2702162,"accession":"0001209191-12-004478","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-004478","line_url":"/filing/0001209191-12-004478#line-3","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II, L.P.; China Renaissance Capital Investment II GP; China Harvest Fund II, LP; Key Gate Investments Ltd","owner_display_name":"China Renaissance Capital Investment II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":21.86,"price_display":"21.86","price_state":"stated","total_value":393480.0,"total_display":"393,480.00","total_whole":"393,480","shares_owned_after":2997674.0,"shares_owned_after_display":"2,997,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-19","filed_date":"2012-01-19","scope":"insider"},{"id":2702157,"accession":"0001209191-12-004478","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-004478","line_url":"/filing/0001209191-12-004478#line-2","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II, L.P.; China Renaissance Capital Investment II GP; China Harvest Fund II, LP; Key Gate Investments Ltd","owner_display_name":"China Renaissance Capital Investment II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24900.0,"shares_display":"24,900","price_per_share":21.91,"price_display":"21.91","price_state":"stated","total_value":545559.0,"total_display":"545,559.00","total_whole":"545,559","shares_owned_after":3015674.0,"shares_owned_after_display":"3,015,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-18","filed_date":"2012-01-19","scope":"insider"},{"id":2702151,"accession":"0001209191-12-004478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-004478","line_url":"/filing/0001209191-12-004478#line-1","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Renaissance Capital Investment II, L.P.; China Renaissance Capital Investment II GP; China Harvest Fund II, LP; Key Gate Investments Ltd","owner_display_name":"China Renaissance Capital Investment II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3041.0,"shares_display":"3,041","price_per_share":21.95,"price_display":"21.95","price_state":"stated","total_value":66749.95,"total_display":"66,749.95","total_whole":"66,750","shares_owned_after":3040574.0,"shares_owned_after_display":"3,040,574","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-17","filed_date":"2012-01-19","scope":"insider"},{"id":2519378,"accession":"0001209191-12-003628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-003628","line_url":"/filing/0001209191-12-003628#line-2","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Harvest Fund II, LP; China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; Key Gate Investments Ltd","owner_display_name":"China Harvest Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87385.0,"shares_display":"87,385","price_per_share":21.89,"price_display":"21.89","price_state":"stated","total_value":1912857.65,"total_display":"1,912,857.65","total_whole":"1,912,858","shares_owned_after":3043615.0,"shares_owned_after_display":"3,043,615","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-12","filed_date":"2012-01-13","scope":"insider"},{"id":2519372,"accession":"0001209191-12-003628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-003628","line_url":"/filing/0001209191-12-003628#line-1","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Harvest Fund II, LP; China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; Key Gate Investments Ltd","owner_display_name":"China Harvest Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8700.0,"shares_display":"8,700","price_per_share":21.91,"price_display":"21.91","price_state":"stated","total_value":190617.0,"total_display":"190,617.00","total_whole":"190,617","shares_owned_after":3131000.0,"shares_owned_after_display":"3,131,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-11","filed_date":"2012-01-13","scope":"insider"},{"id":9268012,"accession":"0001209191-11-062984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-062984","line_url":"/filing/0001209191-11-062984#line-3","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Harvest Fund II, LP; China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; Key Gate Investments Ltd","owner_display_name":"China Harvest Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14807.0,"shares_display":"14,807","price_per_share":21.92,"price_display":"21.92","price_state":"stated","total_value":324569.44,"total_display":"324,569.44","total_whole":"324,569","shares_owned_after":3139700.0,"shares_owned_after_display":"3,139,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-23","filed_date":"2011-12-23","scope":"insider"},{"id":9268013,"accession":"0001209191-11-062984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-062984","line_url":"/filing/0001209191-11-062984#line-2","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Harvest Fund II, LP; China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; Key Gate Investments Ltd","owner_display_name":"China Harvest Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":22.01,"price_display":"22.01","price_state":"stated","total_value":15407.0,"total_display":"15,407.00","total_whole":"15,407","shares_owned_after":3154507.0,"shares_owned_after_display":"3,154,507","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-22","filed_date":"2011-12-23","scope":"insider"},{"id":9268014,"accession":"0001209191-11-062984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-062984","line_url":"/filing/0001209191-11-062984#line-1","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Harvest Fund II, LP; China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; Key Gate Investments Ltd","owner_display_name":"China Harvest Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8910.0,"shares_display":"8,910","price_per_share":22.07,"price_display":"22.07","price_state":"stated","total_value":196643.7,"total_display":"196,643.70","total_whole":"196,644","shares_owned_after":3155207.0,"shares_owned_after_display":"3,155,207","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2011-12-23","scope":"insider"},{"id":9267984,"accession":"0001209191-11-057025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-057025","line_url":"/filing/0001209191-11-057025#line-1","is_derivative":false,"issuer_cik":"0001369786","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001369786","owner_cik":null,"owner_name":"China Harvest Fund II, LP; China Renaissance Capital Investment II GP; China Renaissance Capital Investment II, L.P.; Key Gate Investments Ltd","owner_display_name":"China Harvest Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24386.0,"shares_display":"24,386","price_per_share":25.21,"price_display":"25.21","price_state":"stated","total_value":614771.06,"total_display":"614,771.06","total_whole":"614,771","shares_owned_after":3164117.0,"shares_owned_after_display":"3,164,117","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-11-16","filed_date":"2011-11-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369786","name":"Sagent Pharmaceuticals, Inc.","url":"/issuer/0001369786","role":"Ten percent owner","n_filings":9,"first_seen":"2011-11-18","last_seen":"2012-02-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001518231","retrieved_at":"2026-08-22T07:00:25+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}